Cargando...

Relapsing-Remitting Multiple Sclerosis Patients' Experience with Natalizumab: A Phenomenological Investigation

This phenomenological investigation was undertaken to gain a better understanding of multiple sclerosis (MS) patients' experience with natalizumab (Tysabri; Biogen Idec Inc, Cambridge, MA) treatment and its impact on their quality of life (QOL). Twenty MS patients who were receiving natalizumab...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Miller, Colleen E., Karpinski, Mary, Jezewski, Mary Ann
Formato: Artigo
Lenguaje:Inglês
Publicado: The Consortium of Multiple Sclerosis Centers 2012
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3882975/
https://ncbi.nlm.nih.gov/pubmed/24453731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7224/1537-2073-14.1.39
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!